Cidara Therapeutics (CDTX) Misses Q3 EPS by 310c

Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($3.10).

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• Senior Iranian Official To Reuters: Tehran Is Reviewing U.S. Response To Its Proposal To End Hostilities
• Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
• General Mills beats estimates as cost savings offset volumes